Eagle Bay Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Eagle Bay Advisors's LLY Position: Q1 2026 in Review
Eagle Bay Advisors increased its Eli Lilly (LLY) stake by 4.5% in Q1 2026, buying an estimated $28.4K and bringing the position to 651 shares worth $599K. The position accounts for 0.53% of the portfolio, ranked #44.
Eagle Bay Advisors first reported a position in LLY in Q2 2021 and has held it in 19 quarters since. The position peaked at $718K in Q1 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Eagle Bay Advisors held 651 shares of Eli Lilly worth $599K as of Q1 2026.
- Eagle Bay Advisors bought 28 Eli Lilly shares in Q1 2026, an estimated $28.4K.
- Eli Lilly made up 0.53% of Eagle Bay Advisors's portfolio in Q1 2026, its #44 holding.
- Eagle Bay Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 19 quarters since.
- Eagle Bay Advisors's Eli Lilly position peaked at $718K in Q1 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.